{"nct_id":"NCT04227106","title":"Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2020-01-10","start_date_type":"ACTUAL","primary_completion_date":"2022-10-18","primary_completion_date_type":"ACTUAL","completion_date":"2022-10-18","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABEO"]}